Carla Duarte Study Coordinator CEC - Centre for Clinical Trials

 

Personal data

Publications

• Schmidt-Erfurth U., Eldem B., Guymer R., Korobelnik J.F., Schlingemann R.O., Axer-Siegel R., Wiedemann P., Simader C., Gekkieva M., Weichselberger A.; EXCITE Study Group Efficacy and safety of monthly versus quarterly ranibizumab treatment in neovascular age-related macular degeneration: the EXCITE study. [more info]
• Campochiaro P.A., Brown D.M., Pearson A., Ciulla T., Boyer D., Holz F.G., Tolentino M., Gupta A., Duarte L., Madreperla S., Gonder J., Kapik B., Billman K., Kane F.E. and FAME Study Group Long-term Benefit of Sustained-Delivery Fluocinolone Acetonide Vitreous Inserts for Diabetic Macular Edema. [more info]
• The Macugen Diabetic Retinopathy Study Group Changes in Retinal Neovascularization after Pegaptanib (Macugen) Therapy in Diabetic Individuals. [more info]